Extendicare (EXE.TO) Stock Price

Extendicare Price

TSX·CLOSED
38.27CAD-0.52 (-1.35 %)
Market closed

Revenue at Extendicare has contracted by 0.2% per year over the past 19 years to 1.66 B CAD. Earnings per share have grown at 0.8% per year over the last 18 years. For Extendicare, the net margin of 5.8% is up versus 1.0% a few years ago. At today's price the dividend yield works out to roughly 1.31%. The payout ratio is around 45% of earnings. The dividend has grown at 1.4% per year over the past 19 years. The consensus 12-month price target for Extendicare is 24.48 CAD, about 36.0% below where the stock trades today. Of 10 analysts, 8 rate the stock a buy — an overall Buy consensus. Extendicare's share price has gained 201.3% over the last twelve months. The stock trades about 212% above its 52-week low.

Extendicare stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Extendicare over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Extendicare stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Extendicare's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Extendicare Stock Price History
DateExtendicare Price
7/20/202638.27 CAD
7/17/202638.79 CAD
7/16/202637.23 CAD
7/15/202636.99 CAD
7/14/202637.10 CAD
7/13/202636.99 CAD
7/10/202637.00 CAD
7/9/202637.05 CAD
7/8/202636.98 CAD
7/7/202637.00 CAD
7/6/202637.30 CAD
7/3/202637.45 CAD
7/2/202635.75 CAD
6/30/202635.07 CAD
6/29/202635.41 CAD
6/26/202635.32 CAD
6/25/202635.01 CAD
6/24/202635.37 CAD
6/23/202634.13 CAD
6/22/202634.05 CAD
6/19/202634.23 CAD
6/18/202633.78 CAD
6/17/202633.12 CAD
6/16/202633.50 CAD
6/15/202632.87 CAD
6/12/202632.73 CAD
6/11/202632.50 CAD
6/10/202633.69 CAD
6/9/202632.97 CAD
6/8/202632.85 CAD
6/5/202632.77 CAD
6/4/202632.11 CAD
6/3/202630.90 CAD
6/2/202630.61 CAD
6/1/202631.47 CAD
5/29/202632.32 CAD
5/28/202633.01 CAD
5/27/202633.66 CAD
5/26/202633.15 CAD
5/25/202633.86 CAD
5/22/202633.84 CAD
5/21/202633.41 CAD
5/20/202634.25 CAD
5/19/202634.03 CAD
5/15/202633.32 CAD
5/14/202633.13 CAD
5/13/202633.31 CAD
5/12/202631.98 CAD
5/11/202631.81 CAD
5/8/202633.44 CAD
5/7/202630.20 CAD
5/6/202630.17 CAD
5/5/202630.20 CAD
5/4/202630.30 CAD
5/1/202630.19 CAD
4/30/202629.98 CAD
4/29/202630.19 CAD
4/28/202630.14 CAD
4/27/202629.90 CAD
4/24/202629.61 CAD
4/23/202628.71 CAD
4/22/202628.34 CAD
4/21/202627.98 CAD
4/20/202628.69 CAD
4/17/202629.10 CAD
4/16/202629.78 CAD
4/15/202629.59 CAD
4/14/202629.56 CAD
4/13/202629.43 CAD
4/10/202629.63 CAD
4/9/202629.52 CAD
4/8/202628.81 CAD
4/7/202628.34 CAD
4/6/202628.14 CAD
4/2/202627.76 CAD
4/1/202626.78 CAD
3/31/202626.32 CAD
3/30/202625.84 CAD
3/27/202626.19 CAD
3/26/202625.49 CAD
3/25/202625.56 CAD
3/24/202625.40 CAD
3/23/202625.57 CAD
3/20/202625.50 CAD
3/19/202626.11 CAD
3/18/202626.62 CAD
3/17/202627.05 CAD
3/16/202626.98 CAD
3/13/202626.35 CAD
3/12/202626.42 CAD
3/11/202626.43 CAD
3/10/202626.64 CAD
3/9/202626.18 CAD
3/6/202626.29 CAD
3/5/202626.38 CAD
3/4/202627.05 CAD
3/3/202626.22 CAD
3/2/202626.43 CAD
2/27/202626.58 CAD
2/26/202624.15 CAD
2/25/202624.49 CAD
2/24/202624.73 CAD
2/23/202625.67 CAD
2/20/202624.55 CAD
2/19/202624.62 CAD
2/18/202624.83 CAD
2/17/202625.03 CAD
2/13/202624.99 CAD
2/12/202624.66 CAD
2/11/202624.50 CAD
2/10/202624.03 CAD
2/9/202623.75 CAD
2/6/202623.99 CAD
2/5/202624.21 CAD
2/4/202623.89 CAD
2/3/202623.82 CAD
2/2/202623.89 CAD
1/30/202623.19 CAD
1/29/202623.33 CAD
1/28/202623.40 CAD
1/27/202623.10 CAD
1/26/202622.75 CAD
1/23/202622.21 CAD
1/22/202622.57 CAD
1/21/202622.50 CAD
1/20/202622.61 CAD
1/19/202622.65 CAD
1/16/202622.54 CAD
1/15/202622.28 CAD
1/14/202622.15 CAD
1/13/202622.33 CAD
1/12/202622.12 CAD
1/9/202621.89 CAD
1/8/202622.00 CAD
1/7/202621.39 CAD
1/6/202621.59 CAD
1/5/202621.56 CAD
1/2/202621.08 CAD
12/31/202521.35 CAD
12/30/202521.40 CAD
12/29/202521.24 CAD
12/24/202521.32 CAD
12/23/202521.80 CAD
12/22/202522.22 CAD
12/19/202522.07 CAD
12/18/202522.35 CAD
12/17/202521.99 CAD
12/16/202521.95 CAD
12/15/202522.70 CAD
12/12/202522.36 CAD
12/11/202522.23 CAD
12/10/202522.79 CAD
12/9/202522.87 CAD
12/8/202522.98 CAD
12/5/202522.33 CAD
12/4/202522.08 CAD
12/3/202520.99 CAD
12/2/202520.44 CAD
12/1/202520.53 CAD
11/28/202520.55 CAD
11/27/202520.99 CAD
11/26/202520.83 CAD
11/25/202520.73 CAD
11/24/202520.66 CAD
11/21/202520.25 CAD
11/20/202519.94 CAD
11/19/202520.55 CAD
11/18/202520.09 CAD
11/17/202519.76 CAD
11/14/202519.64 CAD
11/13/202519.18 CAD
11/12/202518.44 CAD
11/11/202515.94 CAD
11/10/202516.14 CAD
11/7/202516.17 CAD
11/6/202516.44 CAD
11/5/202516.47 CAD
11/4/202516.13 CAD
11/3/202516.31 CAD
10/31/202516.06 CAD
10/30/202515.82 CAD
10/29/202515.90 CAD
10/28/202515.94 CAD
10/27/202516.17 CAD
10/24/202516.22 CAD
10/23/202516.08 CAD
10/22/202516.02 CAD
10/21/202515.36 CAD
10/20/202515.41 CAD
10/17/202514.97 CAD
10/16/202514.81 CAD
10/15/202514.82 CAD
10/14/202514.74 CAD
10/10/202514.60 CAD
10/9/202514.66 CAD
10/8/202514.85 CAD
10/7/202514.84 CAD
10/6/202515.00 CAD
10/3/202515.20 CAD
10/2/202515.22 CAD
10/1/202515.16 CAD
9/30/202514.87 CAD
9/29/202515.12 CAD
9/26/202515.12 CAD
9/25/202514.41 CAD
9/24/202514.25 CAD
9/23/202514.28 CAD
9/22/202514.07 CAD
9/19/202513.42 CAD
9/18/202513.36 CAD
9/17/202513.38 CAD
9/16/202513.14 CAD
9/15/202513.31 CAD
9/12/202513.28 CAD
9/11/202513.16 CAD
9/10/202512.94 CAD
9/9/202513.22 CAD
9/8/202513.18 CAD
9/5/202513.11 CAD
9/4/202512.99 CAD
9/3/202512.96 CAD
9/2/202512.93 CAD
8/29/202513.02 CAD
8/28/202513.01 CAD
8/27/202513.10 CAD
8/26/202512.91 CAD
8/25/202513.07 CAD
8/22/202513.31 CAD
8/21/202513.11 CAD
8/20/202513.19 CAD
8/19/202513.30 CAD
8/18/202513.50 CAD
8/15/202513.39 CAD
8/14/202513.48 CAD
8/13/202513.46 CAD
8/12/202513.56 CAD
8/11/202513.28 CAD
8/8/202513.17 CAD
8/7/202512.67 CAD
8/6/202512.66 CAD
8/5/202512.69 CAD
8/1/202512.27 CAD
7/31/202512.33 CAD
7/30/202512.38 CAD
7/29/202512.64 CAD
7/28/202512.39 CAD
7/25/202512.46 CAD
7/24/202512.54 CAD
7/23/202512.70 CAD
Access this data via the Eulerpool API

Extendicare Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
1.17 B CAD
49.71 M CAD
11.50 M CAD
Jan 1, 2022
1.22 B CAD
25.90 M CAD
69.55 M CAD
Jan 1, 2023
1.30 B CAD
62.96 M CAD
33.98 M CAD
Jan 1, 2024
1.47 B CAD
111.21 M CAD
75.21 M CAD
Jan 1, 2025
1.66 B CAD
138.67 M CAD
96.66 M CAD
Jan 1, 2026 (e)
2.24 B CAD
1.44 M CAD
99.11 M CAD
Jan 1, 2027 (e)
2.39 B CAD
229.78 M CAD
116.66 M CAD
Jan 1, 2028 (e)
2.56 B CAD
241.34 M CAD
129.81 M CAD

Extendicare Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 23, 2026, 2:03 PM
 
REVENUEB CAD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM CAD
EBITM CAD
EBIT MARGIN%
NET INCOMEM CAD
NET INCOME GROWTH%
DIV.CAD
DIV. GROWTH%
SHARESM
20132014201520162017201820192020202120222023202420252026e2027e2028e
0.780.820.941.061.101.121.131.161.171.221.301.471.662.242.392.56
-61.564.2115.5612.413.492.101.072.300.694.726.8012.4213.2334.707.026.85
13.5413.2412.6212.2612.3111.9611.7515.7211.328.8511.5813.7114.2214.2214.2214.22
106.00108.00119.00130.00135.00134.00133.00182.00132.00108.00151.00201.00236.00317.89340.21363.53
48.0050.0060.0061.0066.0059.0052.0094.0049.0025.0062.00111.00138.001.00229.00241.00
6.136.136.365.756.025.274.598.124.202.054.757.578.310.049.579.43
5.00-18.00232.0035.002.0031.0028.0054.0011.0069.0033.0075.0096.0099.00116.00129.00
-91.94-460.00-1,388.89-84.91-94.291,450.00-9.6892.86-79.63527.27-52.17127.2728.003.1317.1711.21
0.600.480.480.480.480.480.480.480.480.480.480.510.500.520.520.53
-28.57-20.006.25-1.964.001.92
103.7087.7099.0099.6088.8098.8099.50100.30100.9089.0184.9995.3686.8486.8486.8486.84
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Extendicare generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Extendicare retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Extendicare's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Extendicare has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Extendicare's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Extendicare stock margins

The Extendicare margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Extendicare. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Extendicare.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
11.39 %
4.26 %
0.99 %
Jan 1, 2022
8.88 %
2.12 %
5.69 %
Jan 1, 2023
11.57 %
4.82 %
2.60 %
Jan 1, 2024
13.74 %
7.59 %
5.13 %
Jan 1, 2025
14.26 %
8.35 %
5.82 %
Jan 1, 2026 (e)
14.26 %
0.06 %
4.43 %
Jan 1, 2027 (e)
14.26 %
9.60 %
4.87 %
Jan 1, 2028 (e)
14.26 %
9.44 %
5.08 %

Extendicare Stock Revenue, EBIT, Earnings per Share

The Extendicare earnings per share therefore indicates how much revenue Extendicare has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
11.57 CAD
0.49 CAD
0.11 CAD
Jan 1, 2022
13.72 CAD
0.29 CAD
0.78 CAD
Jan 1, 2023
15.36 CAD
0.74 CAD
0.40 CAD
Jan 1, 2024
15.38 CAD
1.17 CAD
0.79 CAD
Jan 1, 2025
19.12 CAD
1.60 CAD
1.11 CAD
Jan 1, 2026 (e)
25.75 CAD
0.02 CAD
1.14 CAD
Jan 1, 2027 (e)
27.56 CAD
2.65 CAD
1.34 CAD
Jan 1, 2028 (e)
29.44 CAD
2.78 CAD
1.49 CAD

Extendicare business model & stock analysis

Extendicare, Inc. is a Canadian company that has been operating in the healthcare industry for over 50 years. It was founded in 1968 and is headquartered in Markham, Ontario. Translation: Extendicare, Inc. is a Canadian company that has been operating in the healthcare industry for over 50 years. It was founded in 1968 and is headquartered in Markham, Ontario.

Extendicare SWOT Analysis

Strengths

Extendicare Inc has established a considerable presence in the long-term care market. With a large number of facilities and a solid reputation, the company benefits from economies of scale and a loyal customer base.

Extendicare Inc offers a diverse range of services including long-term care, assisted living, and home health care. This allows the company to cater to a wider market and adapt to changing customer needs.

The company employs a skilled workforce consisting of healthcare professionals and support staff. This ensures high-quality care for patients and enhances the company's reputation in the industry.

Weaknesses

Extendicare Inc operates in a highly regulated industry. Changes in government regulations and policies can significantly impact the company's operations and financial performance.

The company relies heavily on government funding for a significant portion of its revenue. Any reduction or changes in government funding could adversely affect Extendicare Inc's financial stability.

As a provider of healthcare services, Extendicare Inc faces the risk of reputation damage if there are any significant incidents or allegations of negligence or substandard care.

Opportunities

The increasing aging population presents an opportunity for Extendicare Inc to expand its services and cater to the growing demand for long-term care and assisted living facilities.

Advancements in technology, such as remote patient monitoring and electronic health records, can improve the efficiency and quality of care provided by Extendicare Inc. Embracing these technologies can enhance the company's competitiveness.

Extendicare Inc has the opportunity to expand its operations into new markets or geographies, either through organic growth or strategic acquisitions. This can diversify the company's revenue streams and reduce its dependence on a single market.

Threats

The long-term care industry is highly competitive, with numerous providers vying for market share. Extendicare Inc faces the threat of losing customers to competitors who offer similar or better services.

The rising costs of healthcare, including labor costs and medical supplies, present a challenge for Extendicare Inc. The company needs to effectively manage these costs to maintain profitability.

Economic instability, including recessions or financial crises, can affect the demand for long-term care services. Extendicare Inc needs to anticipate and adapt to changes in the economic environment to mitigate potential risks.

Extendicare Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Extendicare historical P/E ratio, EBIT multiple, and P/S ratio

Extendicare annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Extendicare shares outstanding

The number of shares of Extendicare was 86.84 M in 2025. This indicates how many shares Extendicare is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
100.90 M Stocks
Jan 1, 2022
89.01 M Stocks
Jan 1, 2023
84.99 M Stocks
Jan 1, 2024
95.36 M Stocks
Jan 1, 2025
86.84 M Stocks
Jan 1, 2026 (e)
86.84 M Stocks
Jan 1, 2027 (e)
86.84 M Stocks
Jan 1, 2028 (e)
86.84 M Stocks

Extendicare stock splits

In Extendicare's history, there have been no stock splits.

Extendicare Dividend History

25 years of dividend payments

YearAnnual DividendYoY ChangePayments
20260.26CAD 48.0%
Jan 30, 20260.04CAD 0.0%1/6
Feb 27, 20260.04CAD 0.0%2/6
Mar 31, 20260.04CAD 4.8%3/6
Apr 30, 20260.04CAD 0.0%4/6
May 29, 20260.04CAD 0.0%5/6
Jun 30, 20260.04CAD 0.0%6/6
20250.50CAD 2.0%12×
Jan 31, 20250.04CAD 0.0%1/12
Feb 28, 20250.04CAD 0.0%2/12
Mar 31, 20250.04CAD 5.0%3/12
Apr 30, 20250.04CAD 0.0%4/12
May 30, 20250.04CAD 0.0%5/12
Jun 30, 20250.04CAD 0.0%6/12
Jul 31, 20250.04CAD 0.0%7/12
Aug 29, 20250.04CAD 0.0%8/12
Sep 29, 20250.04CAD 0.0%9/12
Oct 31, 20250.04CAD 0.0%10/12
Nov 28, 20250.04CAD 0.0%11/12
Dec 31, 20250.04CAD 0.0%12/12
20240.51CAD 6.3%13×
20230.48CAD 0.0%12×
20220.48CAD 0.0%12×
20210.48CAD 0.0%12×
20200.48CAD 0.0%12×
20190.48CAD 0.0%12×
20180.48CAD 0.0%12×
20170.48CAD 0.0%12×

Extendicare dividend history and estimates

In 2025, Extendicare paid a dividend amounting to 0.50 CAD. Dividend means that Extendicare distributes a portion of its profits to its owners.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
0.48 CAD
0.00 CAD
Jan 1, 2022
0.48 CAD
0.00 CAD
Jan 1, 2023
0.48 CAD
0.00 CAD
Jan 1, 2024
0.51 CAD
0.00 CAD
Jan 1, 2025
0.50 CAD
0.00 CAD
Jan 1, 2026 (e)
0.26 CAD
0.26 CAD
Jan 1, 2027 (e)
0.00 CAD
0.52 CAD
Jan 1, 2028 (e)
0.00 CAD
0.53 CAD

Extendicare dividend payout ratio

In 2025, Extendicare had a payout ratio of 44.92%. The payout ratio indicates the percentage of the company's profits that Extendicare distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
436.36 %
Jan 1, 2022
61.54 %
Jan 1, 2023
120.03 %
Jan 1, 2024
41.03 %
Jan 1, 2025
44.92 %
Jan 1, 2026 (e)
45.56 %
Jan 1, 2027 (e)
39.03 %
Jan 1, 2028 (e)
35.36 %

Current Extendicare forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
1.03 %
Buy80.00 % (8)
Hold20.00 % (2)
Sell0.00 % (0)
12M Price Target
24.48
Last Price
37.33
Currency
CAD
12M Return Potential
-34.42 %
LTM Return
0 %

Extendicare Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
8/6/20150.04CAD237.18 MCAD2015 Q2
5/7/20150.03CAD201.89 MCAD2015 Q1
11/6/20140.11CAD549.58 MCAD2014 Q3
8/6/20140.10CAD544.79 MCAD2014 Q2
5/7/20140.06CAD539.88 MCAD2014 Q1
11/6/20130.06CAD506.71 MCAD2013 Q3
8/8/20130.10CAD500.70 MCAD2013 Q2
5/9/20130.11CAD496.00 MCAD2013 Q1
11/8/20110.23CAD533.13 MCAD2011 Q3
8/9/20110.24CAD528.11 MCAD2011 Q2

EESG©

Eulerpool ESG Scorecard© for the Extendicare stock

45/100
6
Environment
62
Social
67
Governance
E

Environment

20
Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Extendicare shareholder structure

% Name
10.87647%
Sandpiper Group
Sandpiper Group
9.56995%
Global Alpha Capital Management Ltd.
Global Alpha Capital Management Ltd.
6.22679%
Geode Capital Management, L.L.C.
Geode Capital Management, L.L.C.
1.20967%
Florida State Board of Administration
Florida State Board of Administration
1.17645%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
1.04326%
Hillsdale Investment Management Inc.
Hillsdale Investment Management Inc.
...

Extendicare Executives and Management Board

MG

Dr. Michael Guerriere

(61)

President, Chief Executive Officer, Director · since 2018

Compensation2.20 M CAD
DB

Mr. David Bacon

Chief Financial Officer, Executive Vice President

Compensation1.29 M CAD
JT

Mr. John Toffoletto

Senior Vice President, Chief Legal Officer and Corporate Secretary

Compensation1.11 M CAD
SP

Mr. Steve Paraskevopoulos

Senior Vice President - ParaMed and Chief Technology Officer

Compensation1.08 M CAD
MM

Dr. Matthew Morgan

Chief Medical Officer

Compensation714,609.00 CAD

Extendicare Supply Chain

Extendicare Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
1 companies
#Name1M3M6M1Y2YTrend
1
-0.27
0.24
0.64
0.33
0.81

Frequently asked questions about Extendicare

The business model of Extendicare Inc. is focused on providing long-term care and healthcare services to seniors in Canada. Extendicare operates a network of retirement and long-term care facilities, offering a range of services such as nursing care, assisted living, memory care, and rehabilitative therapies. The company also provides home healthcare services, including nursing, personal care, and therapy services for individuals living in their own homes. With a commitment to quality care and a person-centered approach, Extendicare aims to enhance the health and well-being of the seniors it serves.

All fundamentals and in-depth analysis of Extendicare

Our stock analysis for Extendicare stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Extendicare. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.